COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT01116219
Brief Title: Bevacizumab, Pemetrexed Disodium, and Cisplatin or Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer. A Multicenter Phase II Trial Including Biopsy at Progression (BIO-PRO Trial).

First Submitted : April 27, 2010
First Submitted that Met QC Criteria : May 3, 2010
First Posted : May 4, 2010 (Estimate)

Last Update Submitted that Met QC Criteria : May 13, 2019
Last Update Posted : May 15, 2019